Notes You Need for July 19: AMZN, ABT, IBM, AA, CSCO, QCOM deal, initial claims, Japan trade, President on dollar and Fed, Russia GDP, White House Fed walk back
In my daily trawling through the market I come upon lots of tidbits of knowledge that I think are important to investors but that don't justify a full post. I've decided to start compiling these notes here each day in a kind of running mini blog that I'm calling Notes...Abbott Lab’s acquisition target St. Jude does indeed have a problem with batteries in its defibrillators
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Abbott looks to acquire its way out of its current growth slump
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...2014 looks to be end-loaded for Abbott Laboratories
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Earnings season even more disappointing than raw numbers say
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...China’s milk wars–what’s going on and winners/losers
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...A low-risk play on global trends: 40% of Abbott’s sales this quarter came from emerging markets
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...10 food stock picks for a post-Smithfield world
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...The $7 billion deal to buy Smithfield is just part of China’s effort to fix its food safety problem–these overseas stocks can help
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...The return of fears about slowing growth reshuffle the valuation deck again
Growth fears have hit the market hard again this morning. And the revival of growth fears shifts the risk/reward on emerging vs. developed markets and extends the upside on safe haven consumer stocks